Enphase Energy Microinverter +8.6% Surge on IQ9S-3P
Can Enphase Energy Microinverter turn a commercial solar launch into a bigger power electronics comeback story? Maik Kemper Editor in Chief “Module wattages keep climbing, and the IQ9S-3P…
SanDisk Record Valuation +10.7% as AI Demand Lifts SNDK
Can SanDisk’s record-breaking AI rally survive once memory supply catches up with today’s extraordinary pricing power? Maik Kemper Editor in Chief Current pricing power is demand-driven, not technology-driven…
Accenture Earnings Drop 14.4% After Outlook Warning
Can Accenture Earnings still justify investor confidence after a sharp sell-off and a weaker revenue outlook? Maik Kemper Editor in Chief AI enthusiasm hasn’t yet translated into meaningful…
Novo Nordisk Wegovy Hits 3M U.S. Prescriptions in 22 Weeks
Has Novo Nordisk Wegovy just delivered the prescription surge that forces Wall Street to rethink the entire obesity trade? Maik Kemper Editor in Chief The oral Wegovy tablet…
DAL Award +1.7% Surge as $3.3B Deal Volume Expands
Is the DAL Award signaling a bigger boom in German infrastructure finance than global investors have priced in? Maik Kemper Editor in Chief Gemeinsam gelingt es uns, auch…
Robinhood Layoffs +2.2% as SpaceX Access Lifts HOOD
Can Robinhood Layoffs really power a lasting breakout, or is this just another hype-fueled spike tied to SpaceX and crypto sentiment? Maik Kemper Editor in Chief Robinhood’s path…
Micron Forecast +3.5%: Targets Rise Before June 24 Earnings
Can Micron’s AI-driven memory rally keep climbing, or has Wall Street already priced in near-perfect earnings? Maik Kemper Editor in Chief We’re underweight the Magnificent Seven — the…
Marvell AI Boom +5.5% as S&P 500 Entry Fuels Surge
Can Marvell’s AI-fueled rally keep climbing as S&P 500 inclusion and hyperscaler demand collide? Maik Kemper Editor in Chief This is infrastructure, not cyclical semiconductor exposure. — Goldman…
Intel Apple Deal +8.2%: 18A-P Breakthrough Lifts Shares
Can the Intel Apple Deal finally turn Intel’s foundry ambitions into a credible challenger to TSMC on U.S. soil? Maik Kemper Editor in Chief We’re going to need…
Moderna Flu Vaccine: FDA Briefing Sets Up Key Vote
Will Moderna Flu Vaccine finally clear the FDA hurdle, or is Wall Street getting ahead of itself again? Maik Kemper Editor in Chief The immunogenicity data in older…